hrs4r
 I want to donate

A centre dedicated to the study of diseases associated with sudden death.

The CGC's research aims to improve knowledge of the associated factors and basic mechanisms that cause cardiovascular disease and sudden death and improve the tools for its diagnostic, prevention, and treatment.

This scientific area is divided into a clinical research area and a basic research area.

CLINICAL RESEARCH: The clinical research program takes advantage of the collaboration of hospitals and health centres to study risk factors, possible treatments, and prevention methods.

BASIC RESEARCH: Studies aimed at better understanding the biological bases of diseases associated with sudden death. The laboratory participates in different projects to understand the physio pathological basis of sudden death in six major aspects: Genetics, epigenetics, histology, electrophysiology, membrane trafficking and proteomics.

Visit Gencardio Diagnostics' website

Main lines of research

Genetic and molecular bases of sudden cardiac death.

Strategic objectives
  • Promote research, teaching and health care quality in the field of heart disease, especially in those that can cause arrhythmias and sudden death
  • Carry out a basic and clinical research program dedicated to cardiovascular disease.
  • The research program is based on the synergy provided by the different specialisms within the group.
  • Provide high-level medical assistance thanks to the incorporation of genetic technology into current methods of diagnosis and treatment.
  • Genetic results allow complementing clinical tests, often insufficient to reach a diagnosis, and customizing treatment options.
  • Develop new genetic tools that improve the diagnosis of patients at risk of cardiovascular disease. Main lines of research
  • Genetic and molecular bases of sudden cardiac death.
Publications

Sarquella-Brugada G, Fernandez-Falgueras A, Cesar S, Arbelo E, Coll M, Perez-Serra A, Puigmulé M, Iglesias A, Alcalde M, Vallverdú-Prats M, Fiol V, Ferrer-Costa C, Del Olmo B, Picó F, Lopez L, García-Alvarez A, Jordà P, Tiron de Llano C, Toro R, Grassi S, Oliva A, Brugada J, Brugada R, Campuzano O

Clinical impact of rare variants associated with inherited channelopathies: a 5-year update.

HUMAN GENETICS, 2022, 141, 1579-1589 dx.doi.org/10.1007/s00439-021-02370-4

Arias Labrador E, Vilaró Casamitjana J, Blanco Díaz S, Ariza Turiel G, Paz Bermejo MA, Pujol Iglesias E, Berenguel Anter M, Fluvià Brugués P, Iglesies Grau J, Brugué Pascual E, Gonzalez Ramírez R, Buxó Pujolràs M, Ramos Blanes R, Brugada Terradellas R

Efectos de un programa interdisciplinar combinado con entrenamiento aeróbico continuo variable y fuerza dinámica en el síndrome coronario agudo.

Rehabilitacion, 2022, 56, 99-107 dx.doi.org/10.1016/j.rh.2021.02.003

Arias Labrador E, Vilaró Casamitjana J, Blanco Díaz S, Ariza Turiel G, Paz Bermejo MA, Brugada Terradellas R

Efectos del entrenamiento de fuerza domiciliario durante el confinamiento por COVID-19 en el síndrome coronario agudo.

Rehabilitacion, 2022, 56, 11-19 dx.doi.org/10.1016/j.rh.2021.04.002

Puigmulé M, Coll M, Pérez-Serra A, López L, Picó F, Neto N, Corona M, Pinsach-Abuin ML, Ferrer-Costa C, Buxó M, Queralt FX, Brugada R

High-quality RNA improves sensitivity of SARS-CoV-2 detection by colorimetric RT-LAMP.

EXPERIMENTAL BIOLOGY AND MEDICINE, 2022, 247, 276-281 dx.doi.org/10.1177/15353702211054768

Carbó-Bagué A, Rubió-Casadevall J, Puigdemont M, Sanvisens A, Oliveras G, Coll M, Del Olmo B, Perez-Bueno F, Marcos-Gragera R

Epidemiology and Molecular Profile of Mucosal Melanoma: A Population-Based Study in Southern Europe.

Cancers, 2022, 14 dx.doi.org/10.3390/cancers14030780

Martínez-Barrios E, Sarquella-Brugada G, Pérez-Serra A, Fernández-Falgueras A, Cesar S, Coll M, Puigmulé M, Iglesias A, Alcalde M, Vallverdú-Prats M, Ferrer-Costa C, Del Olmo B, Picó F, López L, Fiol V, Cruzalegui J, Hernández C, Arbelo E, Grassi S, Oliva A, Toro R, Brugada J, Brugada R, Campuzano O

Discerning the Ambiguous Role of Missense TTN Variants in Inherited Arrhythmogenic Syndromes.

Journal of Personalized Medicine, 2022, 12 dx.doi.org/10.3390/jpm12020241

Alcalde M, Nogué-Navarro L, Tiron C, Fernandez-Falgueras A, Iglesias A, Simon A, Buxó M, Pérez-Serra A, Puigmulé M, López L, Picó F, Del Olmo B, Corona M, Campuzano O, Moral S, Castella J, Coll M, Brugada R

Rare variants in genes encoding structural myocyte contribute to a thickened ventricular septum in sudden death population without ventricular alterations.

FORENSIC SCIENCE INTERNATIONAL-GENETICS, 2022, 58, 102688-102688 dx.doi.org/10.1016/j.fsigen.2022.102688

Zabalza A, Arrambide G, Otero-Romero S, Pappolla A, Tagliani P, López-Maza S, Cárdenas-Robledo S, Esperalba J, Fernández-Naval C, Martínez-Gallo M, Castillo M, Bonastre M, Resina-Salles M, Bertran J, Rodriguez-Barranco M, Carbonell-Mirabent P, Gonzalez M, Merchan M, Quiroga-Varela A, Miguela A, Gómez I, Álvarez G, Robles R, Perez Del Campo D, Queralt X, Soler MJ, Agraz I, Martinez-Valle F, Rodríguez-Acevedo B, Midaglia L, Vidal-Jordana Á, Cobo-Calvo Á, Tur C, Galan I, Castillo J, Río J, Espejo C, Comabella M, Nos C, Sastre-Garriga J, Ramió-Torrentà L, Tintoré M, Montalban X

Is humoral and cellular response to SARS-CoV-2 vaccine modified by DMT in patients with multiple sclerosis and other autoimmune diseases?

MULTIPLE SCLEROSIS JOURNAL, 2022, 28, 1138-1145 dx.doi.org/10.1177/13524585221089540
0

Post-mortem toxicology analysis in a young sudden cardiac death cohort.

FORENSIC SCIENCE INTERNATIONAL-GENETICS, 2022, 59, 102723-102723 dx.doi.org/10.1016/j.fsigen.2022.102723
0

Prevalence of Pathogenic Variants in Cardiomyopathy-Associated Genes in Myocarditis.

Circulation-Genomic and Precision Medicine, 2022, 15 dx.doi.org/10.1161/CIRCGEN.121.003408
Competitive projects
Codi oficial: FI18/00321 Start date:01/01/2019 Data fi: 31/05/2023 Investigador/a principal: RAMON BRUGADA TERRADELLAS Organisme finançador: INSTITUTO DE SALUD CARLOS III Ajuda: 82,400 €
Codi oficial: SEC/FEC-INV-BAS 20/003 Start date:28/10/2020 Data fi: 31/12/2024 Investigador/a principal: OSCAR CAMPUZANO LARREA Organisme finançador: SOCIEDAD ESPAÑOLA DE CARDIOLOGIA Ajuda: 15,000 €
Codi oficial: GINA-COVID Start date:20/07/2021 Data fi: 30/07/2024 Investigador/a principal: RAMON BRUGADA TERRADELLAS Organisme finançador: FUNDACIO LA MARATO TV3 Ajuda: 116,997.50 €
Codi oficial: ODISEA Start date:01/07/2022 Data fi: 30/06/2023 Investigador/a principal: JAIME ABOAL VIÑAS Organisme finançador: FUNDACIÓ ACADÈMIA CIÈNCIES MÈDIQUES Ajuda: 10,000 €
Codi oficial: 101057509 Start date:01/11/2022 Data fi: 31/10/2027 Investigador/a principal: RAMON BRUGADA TERRADELLAS Organisme finançador: EUROPEAN COMISSION Ajuda: 218,975 €
Codi oficial: SLT021/21/000015 Start date:01/04/2022 Data fi: 31/12/2024 Investigador/a principal: RAMON BRUGADA TERRADELLAS Organisme finançador: GENERALITAT DE CATALUNYA Ajuda: 8,400 €
Codi oficial: 2021 LLAV 00073 Start date:11/10/2022 Data fi: 10/07/2023 Investigador/a principal: RAMON BRUGADA TERRADELLAS Organisme finançador: AGENCIA DE GESTIO D'AJUTS UNIV. I RECER. Ajuda: 20,000 €
Codi oficial: ODISEA Start date:01/07/2022 Data fi: 30/06/2023 Investigador/a principal: JAIME ABOAL VIÑAS Organisme finançador: SOCIEDAD ESPAÑOLA DE CARDIOLOGIA Ajuda: 22,500 €
Codi oficial: Girona, territori cardioprotegit Start date:01/07/2022 Data fi: 31/10/2025 Investigador/a principal: RAMON BRUGADA TERRADELLAS Organisme finançador: DIPUTACIO DE GIRONA Ajuda: 99,741.87 €
Codi oficial: Estudio PREV Start date:01/11/2021 Data fi: 31/12/2025 Investigador/a principal: SERGI MORAL TORRES Organisme finançador: FUNDACION MERCK SALUD Ajuda: 0 €
Job offers

Team

If you are a researcher and you are interested in collaborating with any of our research groups, please fill in this form.
I am interested in
If you are a student or you want to do an internship with any of our research groups, please fill in this form.
I am interested in

About IDIBGI!

menu